2013 : FDA Approved Drugs

1. Kynamro (mipomersen sodium); For the treatment of homozygous familial hypercholesterolemia, Approved January 2013

2.Tocilizumab (ocilizumab ) - For the treatment of Polyarticular Juvenile Idiopathic Arthritis, Approved May 2013

Also Indicated in

a. Rheumatoid arthritis
b. Castleman's disease

3. Canakinumab) : For the treatment of Systemic Juvenile Idiopathic Arthritis, Approved May 2013

4. Cysteamine bitartrate) : For the management of nephropathic cystinosis, Approved May 2013

5. Regorafenib : (oral multi-kinase inhibitor ) For the treatment of gastrointestinal stromal tumor, Approved February 2013

6. Radium Ra 223 dichloride : For the treatment of prostate cancer with bone metastases, Approved May 2013